Advertisement
Screener

Ghost Tree Capital, LLC Historic Quarter Change: USA Stocks, New, 2015 Q2

Ghost Tree Capital, LLC historic quarter change: USA Stocks, New

In share positions in stocks (listed in the US), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 144 positions, added to 89, reduced 77 and sold out of 127.

  • Q2 2015: Stock BIIB; Country of operation United States; Class COM; Shares before 0.
  • Q2 2015: Stock ISRG; Country of operation United States; Class COM NEW; Shares before 0.
  • Q2 2015: Stock VRTX; Country of operation United States; Class COM; Shares before 0.
  • Q2 2015: Stock ESPR; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2015BIIB
BIOGEN INC
United StatesCOM030,000+30,000$0$12,118,000+$12,118,0002015-09-09
Q2 2015ISRG
INTUITIVE SURGICAL INC
United StatesCOM NEW020,000+20,000$0$9,690,000+$9,690,0002015-09-09
Q2 2015VRTX
VERTEX PHARMACEUTICALS INC
United StatesCOM060,000+60,000$0$7,409,000+$7,409,0002015-09-09
Q2 2015ESPR
ESPERION THERAPEUTICS INC NE
United StatesCOM075,000+75,000$0$6,132,000+$6,132,0002015-09-09
Q2 2015NBIX
NEUROCRINE BIOSCIENCES INC
United StatesCOM0122,500+122,500$0$5,851,000+$5,851,0002015-09-09
Q2 2015DXCM
DEXCOM INC
United StatesCOM065,000+65,000$0$5,199,000+$5,199,0002015-09-09
Q2 2015QURE
UNIQURE NV
SHS0185,000+185,000$0$4,995,000+$4,995,0002015-09-09
Q2 2015VNDA
VANDA PHARMACEUTICALS INC
United StatesCOM0350,000+350,000$0$4,442,000+$4,442,0002015-09-09
Q2 2015IRWD
IRONWOOD PHARMACEUTICALS INC
United StatesCOM CL A0350,000+350,000$0$4,221,000+$4,221,0002015-09-09
Q2 2015ELV
ANTHEM INC
United StatesCOM020,000+20,000$0$3,283,000+$3,283,0002015-09-09
Q2 2015VCYT
VERACYTE INC
United StatesCOM078,386+78,386$0$873,000+$873,0002015-09-09
Q2 2015BCRX
BIOCRYST PHARMACEUTICALS
United StatesCOM045,000+45,000$0$672,000+$672,0002015-09-09
Q2 2015GKOS
GLAUKOS CORP
United StatesCOM015,000+15,000$0$435,000+$435,0002015-09-09
Q2 2015XENE
XENON PHARMACEUTICALS INC
COM037,500+37,500$0$432,000+$432,0002015-09-09

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet